10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announces that it has signed a definitive agreement to acquire Scale Biosciences, Inc., a leader in innovative and scalable single cell analysis. The acquisition provides 10x with key inventions and technologies that will advance innovation across the company’s Chromium platform. It also helps broaden access to single cell analysis by making it more powerful, affordable, and accessible to researchers worldwide. Scale Biosciences was founded by a multidisciplinary team of scientists and technologists with expertise in next generation sequencing, genomics, and bioinformatics.
Read the full article: 10x Genomics to Acquire Scale Biosciences //
Source: https://www.prnewswire.com/news-releases/10x-genomics-to-acquire-scale-biosciences-302524711.html